Volume 10, Issue 3 (Iranian Quarterly Journal of Breast Disease 2017)                   ijbd 2017, 10(3): 7-20 | Back to browse issues page

XML Persian Abstract Print


1- Quality of Life Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR
2- Quality of Life Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR , sha_haghighat@yahoo.com
Abstract:   (5218 Views)
Introduction: This study aimed to evaluate the effects of yoga on lymphedema volume, range of motion and quality of life (QOL) in women with Breast Cancer Related Lymphedema (BCRL).
Methods: This is a non-randomized semi-experimental clinical trial. Women with BCRL were allocated to receive either Complete Decongestive Therapy (CDT), n = 18) or CDT with an 8-week yoga intervention (n = 18). Outcomes were the volume of arm lymphedema, range of motion (ROM) and QOL. A measurement was conducted at baseline, post-intervention and 4 weeks after the end of intervention.
Results: It was shown that the edema volume decreased and QOL and ROM increased compared to baseline measurements. However the inter-group changes were not significant regarding the scores of QOL (p = 0.536), edema volume (p = 0.846) and ROM (p = 0.209) during the study.
Conclusion: It appears that the yoga intervention with CDT is not superior to CDT alone in lymphedema treatment. Regarding patients’ access to yoga classes and absence of side effects, further studies about its effects and cost-effectiveness are recommended.
 
Full-Text [PDF 102 kb]   (2462 Downloads)    
Conclusion: It appears that the yoga intervention with CDT is not superior to CDT alone in lymphedema treatment. Regarding patients’ access to yoga classes and absence of side effects, further studies about its effects and cost-effectiveness are recommended.
 
Type of Study: Research | Subject: Breast Diseases
Received: 2017/12/27 | Accepted: 2017/12/27 | Published: 2017/12/27

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.